SCHEMBL22414878

SCHEMBL22414878

O=C(COc1cc2cc(Cl)ccc2c2ccccc12)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 1/20 0.47
▸ TNKS O95271 1/20 0.47
▸ PARP1 P09874 1/20 0.47
▸ ROCK1 Q13464 1/20 0.47
▸ PARP14 Q460N5 1/20 0.47
▸ PARP10 Q53GL7 1/20 0.47
▸ PARP2 Q9UGN5 1/20 0.47
▸ PARP3 Q9Y6F1 1/20 0.47
▸ MAPT P10636 6/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ HPGD P15428 3/20 0.44
▸ PTGDR2 Q9Y5Y4 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ TRPM4 Q8TD43 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22414866 0.91 MAPT (0.46) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL22414749 0.91 ROCK2 (0.46) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL22414669 0.90 ROCK2 (0.47) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL22414714 0.86 ROCK2 (0.53) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL9787090 0.77 TDP1 (0.69) MAPTL3MBTL1TDP1NPC1RAB9A
SCHEMBL31531952 0.77 TDP1 (0.69) MAPTL3MBTL1TDP1NPC1RAB9A
SCHEMBL22414662 0.76 MAPT (0.50) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL10675993 0.75 LMNA (0.57) MAPTTDP1MEN1KMT2ANPC1
SCHEMBL10260277 0.75 ROCK2 (0.73) ROCK2TNKSPARP1ROCK1PARP14
SCHEMBL11646129 0.75 ROCK2 (0.57) ROCK2TNKSPARP1ROCK1PARP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127951-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-04-27 — — US disclosed
US-20230127951-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-04-27 — — US disclosed
US-20200283426-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2020-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127951-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC25A21, SLCO4C1, SLCO2A1 ROCK2 4657/4885TNKS 2745/4885PARP1 1799/4885
US-20200283426-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE USE1, SLC16A1, SLCO4C1 ROCK2 4630/4885TNKS 1975/4885PARP1 1147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback